Edit Content

Contact Us


    Human Verification

    Research & Pharma Services

    Innovative assays that can help answer your most challenging genomic questions, comprehensively

    Genomic Testing Cooperative (GTC) offers a broad range of DNA and RNA sequencing services, AI-driven software’s, analysis tools and support services for research projects and clinical trials. Our assays can be tailored to meet your clinical trial requirements and expanded upon as needed.

    Therapeutic areas we have expertise: 

    Solid
    Tumor

    Hematologic
    Malignancies

    Liquid
    Biopsy

    Molecular and
    Traditional IHC Assays

    AI
    Algorithms

    Customized
    Assays

    How we can help you

    GTC Research

    Learn more 

    Please fill up the following form and a member of our staff shall contact you for more details, answering any questions you may have.




      The Co-Op Network

      • GTC has numerous co-op members who can be used as testing sites or trial enrollment sites.  
      • Assays can be transferred to any lab in the world to help support trial needs in any country.
      • Leverage the power of multiple institutions for broader perspectives on testing, therapeutic implementation, data and more… 

      Why GTC:

      • Unique menu offering numerous innovative NGS applications 
      • Rapid turn-around time 
      • Project scalability 
      • Robust AI and deep learning platform to help with report interpretation 
      • World class expertise in both hematologic cancers, solid tumors and immuno-oncology 
      • Access to over 40k data records 

      GTC’s Assays

      Liquid Trace™ (cfDNA and cfRNA)

      • Pan tumor assay for both solid tumors and hematologic malignancies
      • Full gene sequences of 284 DNA genes and 1501 RNA genes
      • Reliable fusion detection of both known and novel genes
      • Covers numerous biomarkers like HRR, PD-L1, HER2 and more
      • Includes viral DNA testing for HPV and EBV

      Liquid Trace™:

      Solid Tumor Profile
      284 / 1501 Genes
      • Indications


        Chromosomal abnormalities, gene amplifications, HRR, MRD, ALK, ROS1, RET, NTRK1/2/3, BRAF, CIC, EWSR1, PD-L1, MET exon 14 skipping and various alternative splicing, MET, HER2, PIK3CA, PTEN, EGFR amplification, AKT1, RAS
      • Sample Type

        Peripheral blood
      • Results Reported

        DNA+RNA
      • Monitoring
      • Therapeutic
      • Prognostic
      • Heterogeneity
      • Clinical Trial Matching

      Liquid Trace™:

      Hematology Profile
      284 / 1501 Genes
      • Indications


        Chromosomal abnormalities, gene amplifications, multiple myeloma, lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia, MDS, CMML, AML, MPN, lymphoma, MRD, VEXAS syndrome, HPV, EBV
      • Sample Type

        Peripheral blood
      • Results Reported

        DNA+RNA
      • Diagnostic
      • Therapeutic
      • Prognostic
      • Heterogeneity
      • Clinical Trial Matching

      Solid Tumor Profile Plus

      • Pan tumor assay focused on solid tumors
      • 434 DNA genes and 1501 RNA genes
      • Covers major biomarkers like MSI, TMB, HRD and more
      • Detect chromosomal structural changes
      • Reliable fusion detection,
      • Alternative splicing,
      • Gene expression
      • Exon skipping
      • Immune profiling

      Solid Tumor

      Profile Plus™
      434 / 1501 Genes
      • Indications

        ALK, ROS1, RET, NTRK1/2/3, BRAF, CIC, EWSR1, PD-L1, MET exon 14 skipping and various alternative splicing, MET, HER2, EGFR amplification, PIK3CA, PTEN, AKT1, RAS and HRD
      • Sample Type

        FFPE

        -
      • Results Reported

        DNA+RNA
      • Diagnostic
      • Therapeutic
      • Prognostic
      • Heterogeneity
      • Clinical Trial Matching

      Hematology Profile Plus

      • Pan tumor assay focused on hematologic malignancies
      • 179 DNA genes and 1501 RNA genes
      • Classify all subtypes of leukemia, lymphomas, myelomas, MDS, VEXAS, CHIP and more
        • AML
        • CMML
      • Detect chromosomal structural changes and chromosomal rearrangements
      • Gene expression

      Hematology

      Profile Plus™
      179 / 1501 Genes
      • Indications

        Classification and diagnosis of lymphoma, multiple myeloma, acute lymphoblastic leukemia, acute myeloid leukemia Includes IgVH mutation status
      • Sample Type

        Bone marrow,
        Peripheral blood,
        Fresh tissue
      • Results Reported

        DNA+RNA
      • Diagnostic
      • Therapeutic
      • Prognostic
      • Heterogeneity
      • Clinical Trial Matching

      Immunohistochemistry (IHC)

      GTC has added Immunohistochemistry (IHC) testing to complement our next-gen sequencing capabilities. We can bring up an antibody or assay to use in your research project. Our NGS can also do a comparison of the IHC and NGS findings. 
      Capabilities include: 

      • Histology 
      • Custom IHC 
      • Image analysis  

      AI Algorithms

      GTC offers several world class AI software’s available for your research and clinical trial projects with multiple publications in top journals. Our AI tools can assist with:

      • Picking the correct cut offs for biomarkers
      • Identify responders from non-responders
      • Other critical testing algorithms

      Our AI software’s can be customized and tuned to work with any assay

      Customized Assays

      Genomic Testing Cooperative (GTC) offers all types sequencing services for research projects and clinical trials. We provide a wide range of capabilities from Sanger sequencing to next generation sequencing. All projects are performed in our CAP and CLIA accredited laboratory by Clinical Laboratory Specialists (CLS).

      We can provide several standard tumor profiling panels or we can collaborate on custom panel development for projects in the field of oncology and immuno-oncology. All studies have optional bioinformatics support and access to our deep learning tools or GTC can deliver raw data files for interpretation with your own tools.

      Types of Pharma and Research Support Services We Offer:

      • Next-gen sequencing
      • Sanger sequencing
      • RNA-analysis
      • Solid tumor research
      • Hematology research
      • Liquid biopsy
      • Custom assay development
      • AI analysis
      • Bioinformatics support
      • CDx development
      • Biomarker discovery

      GTC has a collaboration agreement in place with laboratories to perform IHC and flow cytometry and can perform additional services and capabilities beyond sequencing if your project requires it.

      Contact Us to learn more about our model of cooperation